For Investors
The Second Wave of Consolidation
Access Canada's high-growth medical aesthetics, longevity and wellness sector through a disciplined, operator-led platform that fixes what the first wave got wrong.
30+
Targets Engaged
16%
Market CAGR Through 2030
3,800+
Canadian Clinics
81%
Independently Owned
Who We Are
Built to Fix What
the First Wave Broke
The first wave of clinic consolidation proved the market opportunity but exposed a fatal flaw: founders lost agency, culture thinned, and centralised "efficiency" created friction at the patient experience level.
Northwyn is the second wave. We acquire high-quality, cash-flowing, medically supervised clinics and empower founders to lead organic growth through an innovative partnership structure focused on transparent, values-driven dealmaking.
We build a data-connected health network that scales performance without compromising clinic culture. Founders optimize the patient experience while Northwyn drives platform-level growth through AI, shared infrastructure, and new verticals like longevity.
Investment Thesis
Why Medical Aesthetics
& Longevity. Why Now.
The Market
The medical aesthetic and preventative healthcare categories have been expanding for decades; people are living longer, spending more out-of-pocket, and demanding measurable outcomes in holistic health and aesthetics. The Canadian market alone encompasses 3,800+ clinics, 81% independently owned, with no dominant consolidator.
The Insight
Meanwhile, the 'AI & longevity' rush is learning the hard lesson: engagement doesn't come from features, it comes from trust and it comes from people. The existing medically supervised clinic network is the distribution.
The Strategy
Buy the distribution (cash-flowing private-pay clinic network). Build infrastructure. Deploy new verticals (longevity & wellness) on a stabilized foundation to expand LTV and margins with low CAC and a new hook for a related customer base.
The Crossover
By wedding the existing medically supervised and well established cash-pay private medical aesthetics market with the burgeoning longevity sector, we capture new clientele to synergize the core business through a longevity hook, and cross-sell longevity with the existing loyal and established aesthetic clientele. While not always the case, there is a clear crossover between customers desiring to look better, and live longer and healthier lives.
Market Solving Deal Structure
Our proprietary Uplift Equity Roll (UER) lets founders retain economic interest at the clinic level with uncapped upside, a structure designed to solve the misalignment that broke the first wave of consolidation.
Why Northwyn
Our Competitive Edge
Market Solving Deal Structure
Our proprietary Uplift Equity Roll (UER) lets founders retain economic interest at the clinic level with uncapped upside, a structure designed to solve the misalignment that broke the first wave of consolidation.
Experienced Execution Team
A seasoned team of operators, investors, and industry veterans who have built and scaled healthcare businesses, bringing hands-on expertise to every acquisition and integration.
Proprietary Pipeline Access
A growing pipeline of LOI-signed and advanced-stage targets across Canada, built through deep founder relationships and an industry-leading reputation for fair, transparent dealmaking.
AI Purpose Built
A data-connected health network powered by AI-driven insights, from marketing automation and patient analytics to real-time reporting, driving performance without compromising clinic culture.
Liquidity Ready Platform
Designed from inception with dual-track exit optionality including strategic sale or public markets listing, providing robust downside protection with asymmetric upside potential.
Process
How We Deploy Capital
Source & Screen
Proprietary deal flow from our network of clinic founders, brokers, and industry relationships across Canada.
Evaluate & Diligence
Financial, operational, and clinical due diligence led by our experienced team of operators and investors.
Acquire & Integrate
Structured acquisitions using our Uplift Equity Roll where founders retain equity, stay motivated, and join a data-connected platform.
Grow & Optimize
Margin expansion through shared services, AI-driven insights, procurement leverage, and longevity vertical deployment.
Source & Screen
Proprietary deal flow from our network of clinic founders, brokers, and industry relationships across Canada.
Evaluate & Diligence
Financial, operational, and clinical due diligence led by our experienced team of operators and investors.
Acquire & Integrate
Structured acquisitions using our Uplift Equity Roll where founders retain equity, stay motivated, and join a data-connected platform.
Grow & Optimize
Margin expansion through shared services, AI-driven insights, procurement leverage, and longevity vertical deployment.
Exit Strategy
Liquidity &
Exit Path
Northwyn's legal and operational foundation was designed from inception, through a Liquidity Rights Agreement, to facilitate a dual-track exit across both public and private markets.
Private / Strategic Sale: Our model, including founder alignment, organic growth, economies of scale, long-term cash-flow stability, and platform expansion into longevity, supports attractive outcomes through private sale or strategic acquisition.
Public Markets: Northwyn has real liquidity optionality in U.S. and Canadian public markets once long-term cash stability and consistent organic growth are demonstrated, positioning us as a first-in-class Canadian medical aesthetics and longevity platform.
Bottom Line
Dual-track capability ensures a robust, low-risk investment opportunity combining downside protection with asymmetric upside potential.
Leadership
Meet the Team
Our leadership team brings decades of combined experience across private equity, healthcare operations, and wellness industry management.
Partner With Us
Let's Create
Lasting Value.
Interested in the medical aesthetics space? Let's discuss how Northwyn delivers institutional-quality returns with founder-aligned partnerships.